(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.94%.
Mediwound's earnings in 2026 is -$23,879,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$31,660,460, with the lowest MDWD earnings forecast at -$40,251,024, and the highest MDWD earnings forecast at -$26,145,196. On average, 7 Wall Street analysts forecast MDWD's earnings for 2027 to be -$28,696,824, with the lowest MDWD earnings forecast at -$34,590,724, and the highest MDWD earnings forecast at -$20,889,203.
In 2028, MDWD is forecast to generate -$24,743,598 in earnings, with the lowest earnings forecast at -$25,156,890 and the highest earnings forecast at -$23,988,892.